FDA product code QJQ: Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety
QJQ is the FDA product code for cranial electrotherapy stimulator to treat insomnia and/or anxiety. It is a Class II device, regulated under 21 CFR 882.5800 and reviewed by the Neurology panel. FDA has cleared 19 510(k) submissions under QJQ, 3 in the last five years, from 18 different applicants. The average 510(k) review took 249 days (median 202); 174 days on average over the last three years. FDA has posted 1 recall for QJQ devices, 1 initiated in the last five years.
Definition
To provide electrical current to the head to treat insomnia and/or anxiety
Classification
| Field | Value |
|---|---|
| Device name | Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety |
| Device class | Class II |
| Regulation | 21 CFR 882.5800 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
510(k) clearances per year for QJQ
| Year | Clearances | Avg. review days |
|---|---|---|
| 2019 | 1 | 195 |
| 2023 | 1 | 217 |
| 2024 | 1 | 243 |
| 2025 | 1 | 106 |
Compare with all 510(k) review times · Search every QJQ clearance
Top QJQ applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Medical Consultants Intl. , Ltd. | 2 | 1990-10-04 |
| Neurofield, Inc. | 1 | 2025-12-31 |
| Neurovalens Limited | 1 | 2024-03-27 |
| Neurovalens , Ltd. | 1 | 2023-10-27 |
| Innovative Neurological Devices, LLC | 1 | 2019-03-07 |
13 more applicants have QJQ clearances. See the full list in Caduvo.
Most recent QJQ clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252951 | Neurofield, Inc. | Genesis Sleep | 2025-12-31 | 106 |
| K232253 | Neurovalens Limited | Modius Stress | 2024-03-27 | 243 |
| K230826 | Neurovalens , Ltd. | Modius Sleep | 2023-10-27 | 217 |
| K182311 | Innovative Neurological Devices, LLC | Cervella | 2019-03-07 | 195 |
| K090052 | Johari Digital Healthcare , Ltd. | CRANIAL ELECTRICAL NERVE STIMULATOR, MODEL FM 10/C | 2009-05-29 | 142 |
Recalls for QJQ devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2023-04-06.
| Year | Recalls |
|---|---|
| 2023 | 1 |
Frequently asked questions
What is FDA product code QJQ?
QJQ is the FDA product code for cranial electrotherapy stimulator to treat insomnia and/or anxiety. It is a Class II device, regulated under 21 CFR 882.5800 and reviewed by the Neurology panel.
What device class is QJQ?
Class II, regulation 21 CFR 882.5800. Typical premarket route: 510(k).
How long does a 510(k) take for product code QJQ?
Across 19 cleared submissions the average was 249 days from receipt to decision (median 202).
Which companies have the most QJQ clearances?
Medical Consultants Intl. , Ltd. (2); Neurofield, Inc. (1); Neurovalens Limited (1); Neurovalens , Ltd. (1); Innovative Neurological Devices, LLC (1).
Have QJQ devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2023-04-06.
Next steps
- Run an FDA pathway report with predicate devices for product code QJQ
- Run a recall and safety report across every QJQ manufacturer
- Watch product code QJQ for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times